alexa Abstract | Serum levels of brain-derived neurotrophic factor and clinical efficacy of mirtazapine in geriatric patients with major depression.

Biomedical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

We investigated the clinical efficacy of mirtazapine in Chinese patients with major depressive disorder (MDD) and also examined mirtazapine's effects on the serum brain-derived neurotrophic factor (BDNF) levels in these patients. Fifty-eight geriatric patients with major depression were assigned to an 8-week treatment with either 15 to 45 mg/day of mirtazapine. The efficacy measurements were performed by the Clinical Global Impression rating scales (CGI). Serum BDNF levels were measured using enzyme-linked immunosorbent assay (ELISA). In the study, mean serum BDNF level of untreated depressed patients at baseline was 23.08 ± 11.25 ng/ml and the mean Hamilton Rating Scale for Depression (HRSD) score was 27.8 ± 5.4. After remission was achieved, the mean serum BDNF level was 37.15±20.48 ng/ml whereas the mean HRSD score was 9.6±4.1. After 8 weeks of treatment there was a statistically significant difference in the serum BDNF levels. Meanwhile, HRSD scores and CGI scores were decreased significantly after mirtazapine treatment. Whatever male or female patients, mirtazapine significantly improved serum BDNF levels and decreased the CGI and HRSD scores from baseline. The results showed serum BDNF levels may be considered as a marker of response to mirtazapine antidepressant treatment for Chinese geriatric patients with major depression. And mirtazapine has been an important option for the treatment of major depression in geriatric patients.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Yuqi Zhang Changsong Zhang Zaohuo Cheng Wenwei Xu iaowei Liu Qing Xu Ying Wang Guilin Li Yang Ling Jing Zhu

Keywords

Major depressive disorder, Mirtazapine, geriatric patients, brain-derived neurotrophic factor

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords